
Darryl J. Collins
Examiner (ID: 18520)
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872, 2873, 2507 |
| Total Applications | 2121 |
| Issued Applications | 1862 |
| Pending Applications | 100 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20670457
[patent_doc_number] => 12610950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Method for weed control in lawn or turf
[patent_app_type] => utility
[patent_app_number] => 19/297675
[patent_app_country] => US
[patent_app_date] => 2025-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7334
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19297675
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/297675 | Method for weed control in lawn or turf | Aug 11, 2025 | Issued |
Array
(
[id] => 20320105
[patent_doc_number] => 20250332193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => SKIN TREATMENT USING NO
[patent_app_type] => utility
[patent_app_number] => 19/252324
[patent_app_country] => US
[patent_app_date] => 2025-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19252324
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/252324 | SKIN TREATMENT USING NO | Jun 26, 2025 | Pending |
Array
(
[id] => 20024778
[patent_doc_number] => 20250163000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => AMINO ACID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 19/030589
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19030589
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/030589 | Amino acid compositions | Jan 16, 2025 | Issued |
Array
(
[id] => 20301143
[patent_doc_number] => 12447113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Drug powderization within vials
[patent_app_type] => utility
[patent_app_number] => 19/005284
[patent_app_country] => US
[patent_app_date] => 2024-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 2659
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005284
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/005284 | Drug powderization within vials | Dec 29, 2024 | Issued |
Array
(
[id] => 19875763
[patent_doc_number] => 20250108020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => COMPOSITIONS AND COMPOUNDS CONTAINNG BETA-HYDROXYBUTYRATE AND ONE OR MORE AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/977541
[patent_app_country] => US
[patent_app_date] => 2024-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977541
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/977541 | Compositions and compounds containing beta-hydroxybutyrate and one or more amino acids | Dec 10, 2024 | Issued |
Array
(
[id] => 19743869
[patent_doc_number] => 20250032434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 18/911045
[patent_app_country] => US
[patent_app_date] => 2024-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18911045
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/911045 | Administration of R-beta-hydroxybutyrate and related compounds in humans | Oct 8, 2024 | Issued |
Array
(
[id] => 19496417
[patent_doc_number] => 20240335435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => Roflumilast Formulations with an Improved Pharmacokinetic Profile
[patent_app_type] => utility
[patent_app_number] => 18/744999
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/744999 | Roflumilast formulations with an improved pharmacokinetic profile | Jun 16, 2024 | Issued |
Array
(
[id] => 19768345
[patent_doc_number] => 20250049771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/745005
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745005 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | Jun 16, 2024 | Pending |
Array
(
[id] => 19691172
[patent_doc_number] => 20250009717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON'S DISEASE, PARKINSON'S DISEASE WITH DEMENTIA, DEMENTIA WITH LEWY BODIES, AND MULTIPLE SYSTEM ATROPHY
[patent_app_type] => utility
[patent_app_number] => 18/672743
[patent_app_country] => US
[patent_app_date] => 2024-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672743
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/672743 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON'S DISEASE, PARKINSON'S DISEASE WITH DEMENTIA, DEMENTIA WITH LEWY BODIES, AND MULTIPLE SYSTEM ATROPHY | May 22, 2024 | Pending |
Array
(
[id] => 19570284
[patent_doc_number] => 20240374576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/670960
[patent_app_country] => US
[patent_app_date] => 2024-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670960
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670960 | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors | May 21, 2024 | Issued |
Array
(
[id] => 20066300
[patent_doc_number] => 20250204522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => METHOD FOR MITIGATING HERBICIDE DAMAGE TO COTTON
[patent_app_type] => utility
[patent_app_number] => 18/668598
[patent_app_country] => US
[patent_app_date] => 2024-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18668598
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/668598 | METHOD FOR MITIGATING HERBICIDE DAMAGE TO COTTON | May 19, 2024 | Pending |
Array
(
[id] => 20328404
[patent_doc_number] => 12458661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Selenium disulfide compositions for use in treating meibomian gland dysfunction
[patent_app_type] => utility
[patent_app_number] => 18/665222
[patent_app_country] => US
[patent_app_date] => 2024-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 5584
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665222
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/665222 | Selenium disulfide compositions for use in treating meibomian gland dysfunction | May 14, 2024 | Issued |
Array
(
[id] => 20270185
[patent_doc_number] => 12439945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Method of improving flavor of a composition of (D)-b-hydroxybutyric acid and (D)-1,3 butanediol and use as a nutritional supplement and therapeutic agent
[patent_app_type] => utility
[patent_app_number] => 18/662430
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6369
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662430
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662430 | Method of improving flavor of a composition of (D)-b-hydroxybutyric acid and (D)-1,3 butanediol and use as a nutritional supplement and therapeutic agent | May 12, 2024 | Issued |
Array
(
[id] => 19447192
[patent_doc_number] => 20240307322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Delivery Of Esketamine For The Treatment Of Depression
[patent_app_type] => utility
[patent_app_number] => 18/661125
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 411
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/661125 | Delivery Of Esketamine For The Treatment Of Depression | May 9, 2024 | Pending |
Array
(
[id] => 20465295
[patent_doc_number] => 12521324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Polyurethane gels
[patent_app_type] => utility
[patent_app_number] => 18/653623
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9020
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653623
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653623 | Polyurethane gels | May 1, 2024 | Issued |
Array
(
[id] => 20301162
[patent_doc_number] => 12447132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Metal oxide encapsulated drug compositions and methods of preparing the same
[patent_app_type] => utility
[patent_app_number] => 18/652380
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 56
[patent_no_of_words] => 6148
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652380 | Metal oxide encapsulated drug compositions and methods of preparing the same | Apr 30, 2024 | Issued |
Array
(
[id] => 19379177
[patent_doc_number] => 20240269047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => DRY COMPOSITION FOR AND METHODS FOR FABRICATION OF DRY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/642525
[patent_app_country] => US
[patent_app_date] => 2024-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18642525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/642525 | DRY COMPOSITION FOR AND METHODS FOR FABRICATION OF DRY COMPOSITIONS | Apr 21, 2024 | Abandoned |
Array
(
[id] => 19526475
[patent_doc_number] => 20240350377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METHODS OF FORMING AN ENCAPSULATED CORE MATERIAL, AN ENCAPSULATED MATERIAL, COMPOSITIONS USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/640214
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640214
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640214 | METHODS OF FORMING AN ENCAPSULATED CORE MATERIAL, AN ENCAPSULATED MATERIAL, COMPOSITIONS USES THEREOF | Apr 18, 2024 | Pending |
Array
(
[id] => 20307354
[patent_doc_number] => 20250324983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-23
[patent_title] => METHOD AND APPARATUS FOR CONTROLLING ARTHROPODS USING MASSOIA ESSENTIAL OIL AND RELATED PYRONES
[patent_app_type] => utility
[patent_app_number] => 18/640978
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640978
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640978 | METHOD AND APPARATUS FOR CONTROLLING ARTHROPODS USING MASSOIA ESSENTIAL OIL AND RELATED PYRONES | Apr 18, 2024 | Pending |
Array
(
[id] => 19541708
[patent_doc_number] => 20240358744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/639636
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639636
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639636 | WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF | Apr 17, 2024 | Pending |